These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21487328)
1. Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal disease. Stanford E; Ladhani S; Borrow R; Waight P; Slack M; George R; Balmer P; Miller E; Helbert M Pediatr Infect Dis J; 2011 Jun; 30(6):462-5. PubMed ID: 21487328 [TBL] [Abstract][Full Text] [Related]
2. Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013. Brousseau N; Andrews N; Waight P; Stanford E; Newton E; Almond R; Slack MP; Miller E; Borrow R; Ladhani SN Clin Infect Dis; 2015 Jun; 60(12):1793-801. PubMed ID: 25737376 [TBL] [Abstract][Full Text] [Related]
3. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease. Tamura K; Matsubara K; Ishiwada N; Nishi J; Ohnishi H; Suga S; Ihara T; Chang B; Akeda Y; Oishi K; Vaccine; 2014 Mar; 32(13):1444-50. PubMed ID: 24486367 [TBL] [Abstract][Full Text] [Related]
4. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases. Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505 [TBL] [Abstract][Full Text] [Related]
6. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. Dagan R; Givon-Lavi N; Fraser D; Lipsitch M; Siber GR; Kohberger R J Infect Dis; 2005 Aug; 192(3):367-76. PubMed ID: 15995949 [TBL] [Abstract][Full Text] [Related]
7. Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination. Menon VJ; Corscadden KJ; Fuery A; Thornton RB; Kirkham LA; Richmond PC; Wiertsema SP Vaccine; 2012 Apr; 30(20):3136-44. PubMed ID: 22326775 [TBL] [Abstract][Full Text] [Related]
8. Recurrent invasive pneumococcal disease in children--host factors and vaccination response. Ingels HA Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055 [TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Skinner JM; Indrawati L; Cannon J; Blue J; Winters M; Macnair J; Pujar N; Manger W; Zhang Y; Antonello J; Shiver J; Caulfield M; Heinrichs JH Vaccine; 2011 Nov; 29(48):8870-6. PubMed ID: 21964055 [TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541 [TBL] [Abstract][Full Text] [Related]
11. Persistence of IgG antibody following routine infant immunization with the 7-valent pneumococcal conjugate vaccine. Grant LR; Burbidge P; Haston M; Johnson M; Reid R; Santosham M; Goldblatt D; O'Brien KL Pediatr Infect Dis J; 2015 May; 34(5):e138-42. PubMed ID: 25621761 [TBL] [Abstract][Full Text] [Related]
13. Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood. Salt P; Banner C; Oh S; Yu LM; Lewis S; Pan D; Griffiths D; Ferry B; Pollard A Clin Vaccine Immunol; 2007 May; 14(5):593-9. PubMed ID: 17344347 [TBL] [Abstract][Full Text] [Related]
14. Assignment of Weight-Based Antibody Units for Seven Additional Serotypes to a Human Pneumococcal Standard Reference Serum, 007sp. Goldblatt D; Tan CY; Burbidge P; McElhiney S; McLaughlin L; Tucker R; Rauh M; Sidhu M; Giardina PC Clin Vaccine Immunol; 2015 Nov; 22(11):1154-9. PubMed ID: 26354860 [TBL] [Abstract][Full Text] [Related]
15. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Hidalgo H; Moore C; Leiva LE; Sorensen RU Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116 [TBL] [Abstract][Full Text] [Related]
16. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C. Sikkema DJ; Ziembiec NA; Jones TR; Hildreth SW; Madore DV; Quataert SA Clin Diagn Lab Immunol; 2005 Jan; 12(1):218-23. PubMed ID: 15643011 [TBL] [Abstract][Full Text] [Related]
17. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial. Singleton R; Wenger J; Klejka JA; Bulkow LR; Thompson A; Sarkozy D; Emini EA; Gruber WC; Scott DA Pediatr Infect Dis J; 2013 Mar; 32(3):257-63. PubMed ID: 23001026 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma. Rose MA; Schubert R; Kujumdshiev S; Kitz R; Zielen S Int J Clin Pract; 2006 Nov; 60(11):1425-31. PubMed ID: 17073839 [TBL] [Abstract][Full Text] [Related]
20. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Dagan R; Givon-Lavi N; Porat N; Greenberg D Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]